BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7951261)

  • 41. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
    Myerowitz R; Costigan FC
    J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
    Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
    J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Genetic deficiencies of beta-N-acetylhexosaminidase A and B: Tay-Sachs and Sandhoff diseases (GM2-gangliosidosis)].
    Suzuki K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):721-7. PubMed ID: 2978703
    [No Abstract]   [Full Text] [Related]  

  • 44. A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation.
    Fernandes M; Kaplan F; Natowicz M; Prence E; Kolodny E; Kaback M; Hechtman P
    Hum Mol Genet; 1992 Dec; 1(9):759-61. PubMed ID: 1302612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-hexosaminidase: biosynthesis and processing of the normal enzyme, and identification of mutations causing Jewish Tay-Sachs disease.
    Mahuran DJ
    Clin Biochem; 1995 Apr; 28(2):101-6. PubMed ID: 7628066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tay-Sachs disease screening and diagnosis: evolving technologies.
    Hechtman P; Kaplan F
    DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel human pathological mutations. Gene symbol: HEXA. Disease: Tay-Sachs disease.
    Chin E; Bean L; Coffee B; Hegde MR
    Hum Genet; 2009 Aug; 126(2):329. PubMed ID: 19644708
    [No Abstract]   [Full Text] [Related]  

  • 48. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
    Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
    J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eight novel mutations in the HEXA gene.
    McGinniss MJ; Brown DH; Fulwiler A; Marten M; Lim-Steele JS; Kaback MM
    Genet Med; 2002; 4(3):158-61. PubMed ID: 12180151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
    Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. beta-Hexosaminidase isozymes from cells cotransfected with alpha and beta cDNA constructs: analysis of the alpha-subunit missense mutation associated with the adult form of Tay-Sachs disease.
    Brown CA; Mahuran DJ
    Am J Hum Genet; 1993 Aug; 53(2):497-508. PubMed ID: 8328462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tay-Sachs disease: B1 variant.
    Gordon BA; Gordon KE; Hinton GG; Cadera W; Feleki V; Bayleran J; Hechtman P
    Pediatr Neurol; 1988; 4(1):54-7. PubMed ID: 2976595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two small deletion mutations of the HEXB gene are present in DNA from a patient with infantile Sandhoff disease.
    McInnes B; Brown CA; Mahuran DJ
    Biochim Biophys Acta; 1992 Apr; 1138(4):315-7. PubMed ID: 1532910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.
    Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F
    Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
    Cao Z; Natowicz MR; Kaback MM; Lim-Steele JS; Prence EM; Brown D; Chabot T; Triggs-Raine BL
    Am J Hum Genet; 1993 Dec; 53(6):1198-205. PubMed ID: 7902672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.
    Yamanaka S; Johnson ON; Norflus F; Boles DJ; Proia RL
    Genomics; 1994 Jun; 21(3):588-96. PubMed ID: 7959736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The presence of two different infantile Tay-Sachs disease mutations in a Cajun population.
    McDowell GA; Mules EH; Fabacher P; Shapira E; Blitzer MG
    Am J Hum Genet; 1992 Nov; 51(5):1071-7. PubMed ID: 1307230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new point mutation in the beta-hexosaminidase alpha subunit gene responsible for infantile Tay-Sachs disease in a non-Jewish Caucasian patient (a Kpn mutant).
    Tanaka A; Punnett HH; Suzuki K
    Am J Hum Genet; 1990 Sep; 47(3):568-74. PubMed ID: 2144098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemistry and genetics of Tay-Sachs disease.
    Gravel RA; Triggs-Raine BL; Mahuran DJ
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.